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Heterozygous loss-of-function (LOF)mutations in the gene encoding theDNA-binding protein, SATB2, result in
micrognathia and cleft palate in both humans andmice. In three unrelated individuals, we show that transloca-
tion breakpoints (BPs) up to 896 kb 3′ ofSATB2 polyadenylation site cause a phenotype which is indistinguish-
able from that caused by SATB2 LOF mutations. This syndrome comprises long nose, small mouth,
micrognathia, cleft palate, arachnodactyly and intellectual disability. These BPs map to a gene desert between
PLCL1andSATB2.We identified threeputativecis-regulatory elements (CRE1–3)usingacomparativegenomic
approach eachofwhichwould beplaced in trans relative toSATB2by all threeBPs. CRE1–3 eachbindp300 and
mono-methylated H3K4 consistent with enhancer function. In silico analysis suggested that CRE1–3 contain
one ormore conserved SOX9-binding sites, and this bindingwas confirmedusing chromatin immunoprecipita-
tion on cells derived frommouse embryonic pharyngeal arch. Interphase bacterial artificial chromosome fluor-
escence in situ hybridization measurements in embryonic craniofacial tissues showed that the orthologous
region in mice exhibits Satb2 expression-dependent chromatin decondensation consistent with Satb2 being
a target gene of CRE1–3. To assess their in vivo function, we made multiple stable reporter transgenic lines
for each enhancer in zebrafish. CRE2 was shown to drive SATB2-like expression in the embryonic craniofacial
region. This expression could be eliminated by mutating the SOX9-binding site of CRE2. These observations
suggest that SATB2 and SOX9may be acting together via complex cis-regulation to coordinate the growth of
the developing jaw.
INTRODUCTION
Pierre Robin sequence (PRS) is a clinically important subgroup
of orofacial clefting defined by; micrognathia, U-shaped cleft
palate, glossoptosis andobstructive apnea.Theprimary anomaly
in PRS is considered to be failure of mandibular growth in the
period prior to fusion of the embryonic palate resulting in abnor-
mal placementof the tongue in the primitive oral cavity causinga
physical obstruction to fusionof theposterior palatal shelves (1–
3). A critical role for the collagen species COL2A1, COL11A1
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andCOL11A2 in thepathogenesis ofPRS is suggestedby the iden-
tification of heterozygous, dominant-negative, intragenic muta-
tions in 30% of cases (i.e. Stickler syndrome-related PRS) (4–
6). This role is further supported by the discovery that a proportion
of non-syndromal PRS cases is caused by long-range cis-
regulatory mutations (CRMs) within the large gene desert sur-
rounding SOX9 (7). In the autosomal dominant families reported
with these regulatory mutations affecting SOX9, PRS represents
the most severe end of a spectrum that includes cleft palate with
micrognathia and isolatedmicrognathia. A similar spectrum of se-
verity is seen in Stickler and Stickler-like syndromes. It is notable
that SOX9 is a direct transcriptional activator of COL2A1 and
COL11A2 (8) suggesting that the growth failure of the jaw in
both Stickler and SOX9-related PRSmay have a shared pathogen-
esisviadefects in theconnective tissuematrixduringdevelopment.
We previously reported two-unrelated cases with de novo ap-
parently balanced chromosomal rearrangement (DNABCR)
breakpoints (BPs) involving 2q33 associated with cleft palate,
micrognathia, arachnodactyly, intellectual disability and a char-
acteristic facial appearance (9). BP mapping implicated loss of
function of SATB2 as the cause of the clinical phenotype (10)
with the transcription unit being directly disrupted in one case
and the BP located 130 kb 3′ of the polyadenylation site within
a large gene desert in the other. The latter casewas hypothesized
to represent a CRM. Support for a causative role for SATB2 hap-
loinsufficiency in craniofacial malformations was provided by
patients with independent gene-disrupting DNABCRs (11,12),
whole gene (13–15) and intragenic deletions (16) and a single
nonsense mutation (17) associated with phenotypes that signifi-
cantly overlap with the original cases.
SATB2 is a CUT and HOX domain-containing DNA-binding
protein that shows site- and stage-specific expression during cra-
niofacial and brain development. SATB2 differs in only 3 of 733
amino acids positions between human and mouse primary se-
quence. Human SATB2 is encoded by the SATB2 gene that is
located within chromosome band 2q33 (chr2:200 134 223–
200 329 831 hg19). SATB2 is SUMOylated and associates
with the nuclear matrix in pre-B cells (18). A non-redundant
role for SATB2 in craniofacial development was confirmed
when targeted inactivation of the gene in mouse embryos was
shown to result in severe midline facial malformations in homo-
zygous embryoswith cleft palate also occurring inheterozygotes
at lower penetrance (19). SATB2 also has an important role in
specifying callosal (contralateral intracortical) projection of
post-mitotic neurons in the developing cortex (20,21). SATB2
and SATB1, the only close mammalian homolog, appear to be
paralogs of a single invertebrate gene. InDrosophila melanoga-
ster, this gene is known as defective proventriculus that is
required for wing, midgut, leg joint, ommatidial andmale acces-
sory gland development (22–24).
In this paper, we update and extend the phenotypic characteris-
tics of one of the original cases, re-interpret a case from the litera-
ture and report a further case with de novo balanced reciprocal
translocation BP mapping to the gene desert adjacent to SATB2
associated with PRS and a distinctive craniofacial appearance.
We show that specific regions of this gene desert show SATB2-
transcription-dependent chromatin de-condensation during cra-
niofacialdevelopment.Furthermore,highlyconservednon-coding
elements upstream of this BP bind SOX9 and drive expression
in transgenic animals consistent with them acting as SATB2
enhancers.Wealso confirmandextend the clinical and radiologic-
al features associated with disruption of SATB2 function and
suggest that this represents a clinically recognizable syndrome.
RESULTS
Potential CRM affecting SATB2
Case 1 46,XX,t(2;11)(q32;p14) de novo
This individual was included in the original gene identification
report (10). At that time, the 2q32 BP in this case was postulated
to result in a CRM. She was clinically re-evaluated at the age of
24 years. Her early growth, development and general medical
history are summarized in Table 1. She was noted to have had a
long thin face with a prominent nasal bridge, a small mouth,
micrognathia (Fig. 1A and B) and bilateral arachnodactyly
(Fig. 1C). She has significant intellectual disability and requires
constant supervision for reasons of her personal safety. These fea-
tures were essentially unchanged from the original clinical report
(9). She hada high-resolutionmagnetic resonance imaging (MRI)
ofherbrainanddetailedneuropsychologyassessmentat the ageof
22. TheMRI showed that the left lateral ventricle was larger than
the right, with mild asymmetry of the cerebral hemispheres and
cranium, without obvious malformation. The anterior commis-
sure was small but present. The corpus callosum was present
and unremarkable. Her intellectual level had previously been
assessed to fall within the mild learning disability range IQ of
70–80. Her performance was impaired on measures of verbal
learning and immediate visual recall (,1st centile). She benefited
from rehearsal, and her delayed retentionof both verbal andvisual
material was average (25–50th centile). Her verbal working
memory and verbal fluency were weak (,1st centile). Her per-
formance was impaired on a measure of response inhibition and
a visuospatial apraxia was recorded. These findings imply wide-
spread cognitive difficulties.
Fluorescence in situ hybridization (FISH) mapping of the BPs
of this translocation has been reported previously (25). This
showed the chromosome 2 BP to lie in the interval of chr2:200
000 820–200 010 665 hg19 (Table 1, Fig. 2) 128.5 kb 3′
(centromeric) of the SATB2 polyadenylation site. The chromo-
some 11 BP lies in the interval of chr11:33 461 914–33 544 317
hg19 (Table 1) in an intergenic interval between HIPK3 and
KIAA1549L. The chromosome 11 intergenic region contained
no human-chick conserved potential cis-regulatory elements
(CREs) using the parameters of .80% identity .150 bp
regions using ECR browser (http://ecrbrowser.dcode.org).
Case 2 46XY,t(2;3)(q33.1;q26.33) de novo
A 33-year-old male with PRS and severe intellectual disability
was referred for dysmorphic assessment. He was seen in a
secure psychiatric ward, where hewas detained for reasons of ag-
gressive behavior. A full examination and accurate growth mea-
surements were not possible because of marked agitation. He
had a long, thin face with a prominent nasal ridge, a small
mouth, micrognathia (Fig. 1D and E) and bilateral mild arachno-
dactyly.Theclinical similaritybetween thismanandtheprevious-
ly reported SATB2 translocation cases was noted (see below and
Table 1) and a karyotype showed a de novo reciprocal transloca-
tion, 46XY,t(2;3)(q33.1;q26.33). Metaphase FISH mapping
located the 2q33.1 BP to 760 kb 3′ (centromeric) of the SATB2
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Table 1. Clinical features associated with intragenic and CRMs of SATB2
Intragenic mutations in SATB2 cis-Regulatory mutations
Paper (PMID) 10417281 19668335 17377962 23020937 19170718 18371933 This report This report 21295280
Case Case 1 Case 1 Case 2 Case 3 Case 1 ER52725 Case 1 Case 49 Case 1 Case 2 Case 1
Mutation 46,XX, t(2;7)(q33;p21) de
novo disrupting
SATB2- transcription
unit
chr2:200 309 696–
200 319 784 hg19
Deletion only involving
SATB2:
chr2:200 128 960–
200 312 555 hg19
Deletion only involving
SATB2:
chr2:200 151 982–
200 325 064 hg19
Deletion only involving
SATB2:
chr2:200 151 782–
200 336 956 hg19
Heterozygous SATB2
c.715C.T;
p.R239X;
chr2:200 213 881
hg19
Heterozygous SATB2
chr2:
g.200 213 455AC;
p.Val381Gly de novo
BP disrupting SATB2-transcription
unit; 46,XY,t(2;14)(q33;q22)
de novo; BP
chr2:200 166 659–
200 166 954 hg19
46,XX,t(2;10)(q33;q21.2)
de novo: BP disrupting
SATB2-transcription
unit chr2:200 166 166–
200 203 438 hg19
t(2;11)(q33.1;p13) de
novo; BP within
PLCL1-SATB2
gene desert
between
chr2:200 000 820
and 200 010 665
hg19
46XY,t(2;3)(q33.1;q26.33) de
novo; BP within
PLCL1-SATB2 gene
desert between
chr2:199 380 000 and
199 390 000 hg19
46,XY,t(1;2)(p34;q33)
paternal/
cosegregating. BP
within
PLCL1-SATB2 gene
desert between
chr2:199 214 552
and 199 261 488
hg19
Phenotypic sex F F M F M F M ? F M M
Birth weight (g) 2950 3884 50th %ile ? ? 3070/20.65 3200 ? 3720 3515 ?
Gestation (weeks) 38 ? ? ? ? 34 ? ? 40 41 ?
Age (years) 11 9.7 21 6 36 2.66 0.1 21 24 33 4
Height (cm) 50–75th %ile 25–50th %ile 10th 75th %ile 25th %ile 20.81 Post-natal
growth failure
? 50–75th %ile ? ?
Weight (kg) ? 50–75th %ile 5–10th 50–75th %ile ,3rd %ile NR ? ? 10th %ile ? ?
OFC (cm) 50th %ile 75th %ile .98th 2nd %ile 50th %ile 21.17 ? ? 50–75th %ile ? ?
Small mouth Yes ? ? ? ? Yes Yes ? Yes Yes Yes
Cleft palate Yes No Yes No Yes Bifid uvula Yes Yes Yes Yes Yes
Micrognathia ? Yes Yes ? Yes ? Yes Yes Yes Yes Yes
Obstruct apnea ? ? ? ? ? ? Yes ? No ? ?
Feeding difficulties ? ? Yes ? ? ? Yes ? Yes Yes ?
Prominent nasal bridge Yes No Yes ? No No Yes ? Yes Yes Yes (from photo)
Long nose Yes Yes ? ? Yes No Yes Yes Yes Yes Yes (from photo)
Long columella Yes ? ? ? No No ? ? Yes Yes Yes (from photo)
Arachnodactyly Yes No ? ? ? NR ? Yes Yes Yes ?
Teeth Delayed eruption of
primary dentition
Overcrowded Fused central incisors Marked
overbite
NR N/A Oligodontia Small teeth in primary
dentition now edentulous
Oligodontia
Sat unaided 24 ? ? Late ? NR N/A ? Late 3 years ?
Walked unaided ? ? 2–3 years Late ? NR N/A ? 24 months 5 years ?
Speech delay Yes Yes Yes No speech Yes NR N/A Yes Yes No speech ?
Intellectual disability Moderate IQ ,50 Severe IQ 32 Yes Yes Global developmental delay Yes Mild Severe ?
Neuroimaging ? MRI & CT normal ? ? CT Delayed myelination on
brain MRI
Agenesis of the corpus callosum and
ventriculomegaly
? See Report ? ?
Seizures Tonic clonic No Yes No
Skeletal disorders Osteopenia, Scoliosis NR Osteopenia Scoliosis Osteomalcia diagnosed in
childhood
?
Other features Laryngomalacia and absence of the
epiglottis
Pointed chin, very sociable,
coarse features, high
anterior hairline with
cowlick
Bilateral strabismus
requiring surgery,
excellent long-term
memory
Contented child aggressive
behavior as adult. Severe
gastroesophageal reflux
and constipation
Malar hypoplasia. Father
has the translocation
and a similar
phenotype
Other BP in
translocation
cases
7p21 BP maps between
HDAC9 and
TWISTNB;
chr7:19 222 993–
19 247 899 hg19
N/A N/A N/A N/A N/A 14q22 BP maps to between
TMEM260 and OTX2;
chr14:56 234 451–56 235 572
hg18
10 BP maps between EGR2
and NRBF2;
chr10:64 314 352–
64 495 348 hg18
11p13BPmaps between
HIPK3 and
KIAA1549L
chr11:33 461 914–
33 544 317 hg19
3q26.33 BP maps .27.7 kb 3′
to SOX2 between
chr3:181 460 016 and
181 526 605 hg19
1p34 BP disrupts FAF1
transcription
unit within
the first intron
Reference (PMID) 18374296 19170718 18371933 18374296 This report 21295280
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polyadenylation site within the gene desert between SATB2 and
PLCL1 (chr2:199 380 000–199 390 000 hg19) (Supplementary
Material, Table S1 and Fig. 2). The 3q26.33 BP mapped to a
gene desert 50–80 kb 3′ (telomeric) of SOX2 (chr3:181 460
016–181 526 605) (Supplementary Material, Table S1) in a
region that has not previously been implicated in human
disease. SOX2 heterozygous loss-of-function (het-LOF) muta-
tions are associated with a syndromic form of anophthalmia or
severe microphthalmia (26).
Re-interpretation of a reported case; 46,XY, t(1;2)(p34;q33)
Ghassibe-Sabbagh et al. reported an interesting family in which
cleft palate, micrognathia, microstomia and oligodontia segre-
gated with a 46,XY, t(1;2)(p34;q33) in father and son (27).
The father’s sister had a similar clinical phenotype, but nokaryo-
type information was reported on her. Genome-wide analysis
revealed no copy number variation in the affected son. The BP
at 1p34mappedwithin the first intron ofFAF1, and investigation
of the possible role of this gene in orofacial cleftingwas the focus
of the original report. However, the 2q33 BP-spanning clone
(Table 1, Fig. 2) maps within the PLCL1-SATB2 gene desert
896 kb 3′ (centromeric) of SATB2 polyadenylation site (28).
This BP location combined with the clinical overlap with Case
1, Case 2 and previously reported cases (see below, Table 1)
strongly suggests that these cases have a shared developmental
pathogenesis.
SATB2 het-LOF and CRMs cause the same recognizable
clinical syndrome
Eight cases with het-LOF mutations of SATB2 have been
reported (9,11,12,16,17,29). The available clinical features are
recorded in Table 1 together with those from the three indivi-
duals with potential CRMs. Pre- and post-natal growth appears
normal in all cases apart from the lowadultweight in the individ-
ual with p.R239X. Comparing the assessable features between
the het-LOF and CRM cases, intellectual disability is present
in 8/8 and 3/3, cleft palate in 6/8 and 3/3, micrognathia in 5/5
and 3/3, long nose in 4/5 and 3/3, small mouth in 3/3 and 3/3
and feeding difficulties in 2/2 and 2/2, respectively. Apparently,
heterogeneous dental malformations appear common in both
groups. Osteoporosis or osteomalacia was recorded in three of
the cases.Only one case (in het-LOFgroup) hadbrainmalforma-
tion, this individual had previously been diagnosed as having
Toriello–Carey syndrome (OMIM 217980). It seems likely on
the basis of the overlap of clinical features and facial appearance
that the individuals with putative-SATB2 CRM have the same
condition as those with SATB2 het-LOF. This suggests that the
translocation BPs result in functional haploinsufficiency in
critical-embryonic tissues.
PLCL1-SATB2 gene desert contains multiple conserved
potential CREs
To identify CREs thatmay have been disrupted by the transloca-
tion BPs, we used a comparative genomics approach to the
PLCL1-SATB2 gene desert (Fig. 2C). Using the parameters of
.80% identity .150 bp between the orthologous regions in
human and chick genomes, we identified 42 CREs ranging in
size from 150 to 933 bp (median 251 bp) and from 80 to
94.5% (median 81.1%) identity. Three of these, CRE1–3,
were chosen for analysis as they were disrupted by every BP
and based on their large size and high level of cross-species con-
servation. These elements were named in centromeric to telo-
meric order; CRE1 (933 bp, 91.2%), CRE2 (473 bp, 86.9%)
and CRE3 (909 bp, 94.5%) (for hg19 genomic coordinates, see
Supplementary Material, Table S8). Using chromatin immuno-
precipitation (ChIP) in combination with quantitative real-time
polymerase chain reaction (qPCR), we showed that each of
these elements bound p300 and H3K4 monomethylation
(H3K4me1) in Satb2-expressing cells derived from mouse em-
bryonicpharyngeal arch (MEPA) consistentwith enhancer func-
tion (30) (Fig. 4A). The Sox9-promoter region was used as a
negative control (data not shown) in these experiments as previ-
ously reported (7). Given the high concordance of cleft palate
and micrognathia in the affected individuals, we hypothesized
that SATB2 may be a target of the transcription factor SOX9
as CRMs affecting SOX9 are a significant cause of PRS (7).
Figure1.ClinicalphenotypeofSATB2-relatedPRS.PhotographsofCase1.Sig-
nificant facial features include long nose, micrognathia and small mouth (A and
B).Hands are notable for long slenderfingers (C). Facial photographs ofCase2 at
10 weeks of age (D) and 31 years (E) showing small mouth (D and E), micro-
gnathia (D) and long nose (E).
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A motif-based search of the elements revealed four conserved
sites that would-be predicted to bind SOX9, two in CRE1 and
one each in CRE2 and CRE3 (Supplementary Material,
Fig. S1). The ChIP–qPCR analysis of Sox9 binding in MEPA
cells was consistent with the prediction with all three elements
showing binding to Sox9 with CRE1 showing significantly
greater fold enrichment over the IgG controls compared with
CRE2 and CRE3 (Fig. 4B). A sequence located at the 3′ end of
Col2a1 that had been previously used as a negative control for
Sox9 ChIP (31) likewise showed no enrichment compared
with IgG in Sox9 ChIP from MEPA cells (data not shown).
Plcl1-Satb2 transcription-dependent chromatin
de-condensation
AlthoughCRE1–3have characteristics of enhancers involved in
cis-regulation of developmental genes, itwas necessary to estab-
lish which gene or genes these enhancers were targeting. As a
first step, we examined the degree of chromatin condensation
in vivo within the Plcl1-Satb2 gene desert to determine if the
chromatin state changed in Satb2-expressing cells compared
with those that are transcriptionally silent. We measured the
3D distance between pairs of bacterial artificial chromosome
(BAC) probes in vivo using DNA FISH (Fig. 3D) on developing
craniofacial tissues in 13.5 days post coitum (dpc) mouse
embryos. BACs containing Plcl1 (RP23-453N3), the region
orthologous to the t(2;3) (RP23-310N20) and t(2;11) (RP23-
444L13) and Satb2 (RP24-241H21) were used for the analysis
(Fig. 3A and D). Immunohistochemistry was used to identify
Satb2-expressing and non-expressing tissue (Fig. 3B), and RNA
FISH was used to confirm that both alleles of Satb2 were active
in each cell in the expressing tissues (Fig. 3C). Satb2 is expressed
in the palatal shelves, tongue and mandible (Fig. 3B and C).
The 3D interphase distance across the gene desert (Plcl1 to
Satb2; Interval 1) was similar in all tissues examined as was that
between t(2;3) BP and Satb2 (Interval 3) (Fig. 3E, Supplementary
Material, Tables S2–S4). However, the mean distance between
Plcl1 and the t(2;3) BP (Interval 2) was significantly larger in
Satb2-expressing tissue (Fig. 3E and Supplementary Material,
Tables S2–S4) as was that between the t(2;11) region and Satb2
(Interval 4). These results strongly support Satb2 as the target of
the enhancer activity associated with this locus.
CRE2 drives Sox9-dependent Satb2-like expression
in transgenic zebrafish
Todetermine if CRE1–3 did indeed have SATB2 enhancer func-
tion in vivo, we employed reporter transgenic analysis in zebra-
fish. The reporter constructs consisted of the full-length human
CRE upstream of the mouse Gata2 minimal promotor driving
eGFP. At least three stable lines were established from each
CRE, and embryos were screened at 24 h and the tissue
Figure 2. FISH mapping of translocation BPs with potential cis-regulatory effect. BP spanning clones in Case 2. (A) BAC RP11-258L23 was confirmed as the BP
spanningclone on chromosome2with signal visible on derivative 2 andderivative 3. (B) BACRP11-43F17 isBP spanning cloneon chromosome3with signal visible
on thederivative3 andderivative2. (C)Graphical representationof thePLCL1-SATB2genomic intervalusinghg19coordinates.The interval containing the t(2;3)BP
is shown as a purple box. Orange bars represent human BAC probes that delineated this BP. BACRP11-258L23 was found to span the t(2;3) BP which lies 749 kb
away from SATB2 polyadenylation signal. The intervals containing the BPs for Case 1 (t(2;11)) and Case 3 (t(1;2)) are shown as black boxes. The distance between
each of theseBP and the SATB2polyadenylation signal is indicated by the black lines below.The red lines at the bottomof the graph indicate the presence of potential
CRE at that genomic coordinate with the color of the line indicating the length of the CRE. The CREs labeled 1, 2 and 3 were chosen for further study as these were
potentially disrupted by all of the BPs.
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Figure3. InterphaseFISHmeasurement ofPlcl1-Satb2interval in expressing andnon-expressing tissues. 3Ddistancemeasurements between interphaseFISHsignals
in sections of mouse embryonic tissues reveals localized tissue-specific chromatin decompaction at the Satb2 locus. (A) Genomic organization of the Satb2 locus in
mouse (mm9). Orange bars represent mouse BAC probes used in 3D distance measurements. Gray lines represent the distance of each interval, 1–4, between BAC
probes. Red lines represent potential CREs. In particular, CREs 1, 2 and 3 are potentially disrupted by each reported BP. (B) Confirming Satb2 expression: immuno-
histochemistry in the branchial arch region of a wild-type mouse embryo at 13.5 dpc (coronal section, 4 mm thick). Staining is observed in the palatal shelves (ps),
tongue (t) andmandible (md). Expressing (E) and non-expressing (NE) areaswere examined at 100×magnification in adjacent sections, the former corresponding to
region represented by the RNA FISH image in (C). (C) RNA FISH signals (in red) show Satb2 expression at the cellular level in the left palatal shelf and tongue. (D)
DNAFISH signals ofmouseBACprobe pair RP23-310N0 andRP24-241H21 taken from the right palatal shelf. (E) Optical sectioning of individual nuclei in sections
of 13.5 gestational daysmouse embryonic tissue in Satb2-expressing and non-expressing areas alloweddistances betweenmouseBACprobe signals, four probe pairs
in total, to be measured in 3D. The black lines above a double asterisk indicate a significant transcription-dependent chromatin decondenzation based on a 95% con-
fidence interval (CI) (see Supplementary Material, Tables S2–S4).
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Figure 4.Expression patterns driven bywild-type andmutant SATB2CRE2 in zebrafish reporter transgenics. (A) Graph of the fold enrichment over IgG using ChIP
for H3K4 monomethylation (H3K4me1) and p300 of CRE1–3 in MEPA cells showing that each of the elements binds to p300 and H3K4me1, marks of enhancer
function significantly above background. (B) Graph of the fold enrichment over IgG using Sox9 antibody measures using qPCR for CRE1–3 in MEPA cells
showing that each of the elements also binds SOX9 above background level. (C)mRNA in situ hybridization using an antisense probe for zfSatb2 showing expression
in the developing pharyngeal arch (PA1), ethmoid plate (EP) and eye (E). (D) Cartoon of the constructs used tomake the stable transgenic lines. (E–G) mRNA in situ
hybridizationusingan antisenseprobe for eGFP showing reporter gene expressiondrivenbyCRE2 in embryos collected fromstable zebrafish reporter transgenic line.
CRE2driveseGFPexpression in thedevelopingeye (E), ethmoidplate (EP),olfactoryplacode (OP),brain (BR), andpharyngealarch (PA1).The sameelementbearing
mutations in thepredictedSOX9-bindingsites (H–J) fails todrivea similar expressionpattern.The reporter activity in themutant lineswasdetectedusinganantisense
probe for mCherry.
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distribution and consistency of reporter activity recorded by
fluorescence microscopy. Only CRE2 resulted in transgenic
lines that each gave an expression pattern which accurately
represented a subset of endogenous zfSatb2 site- and stage-
specific expression. However, CRE1 drove expression in the
olfactory placode at 48 h, which is a site of Satb2 expression, al-
though endogenous Satb2 expression is not detectable until 96 h
(Supplementary Material, Fig. S2). The CRE2 reporter activity
is represented in Figure 4E–G aswhole-mount in situ hybridiza-
tion (WISH) using an antisense riboprobe to eGFP transcript.
Each line shows expression in the ethmoid plate (Fig. 4E–G).
In CRE2-line3, there is also expression in the first pharyngeal
arch (Fig. 4E) and, in CRE2-line1, there is expression in the
retina that is similar to endogenous zfSatb2.
To determine the role that SOX9 plays in driving the craniofa-
cial expression in the CRE2 element, we introduced a mutation
that was predicted to ablate the single conserved SOX9-binding
site in this element. The construct was otherwise identical apart
from the fact that mCherry replaced eGFP as the fluorescent re-
porter.WISHusing an antisense riboprobe tomCherry transcript
showed that none of the stable lines made using this construct
resulted in an expression pattern that encompassed a subset of
endogenous zfSatb2 (Fig. 4H–J, Supplementary Material,
Table S9). This observation is consistent with the notion that
SOX9 is driving the craniofacial expression of Satb2 via inter-
action with the CRE2 enhancer.
DISCUSSION
Here, we show that translocation BPs that lie in the gene desert 3′
of SATB2 have a clinical consequence which mimics het-LOF
mutations of SATB2. This suggests that the translocation BPs
produce functional haploinsufficiency in, at least, a subset of
developmental tissues with dosage sensitivity for this gene
product. The best-studied example of the cis-regulatory ‘switch
off’ phenomenon has been associated with aniridia (MIM
106210), a panocular developmental eye disorder in which most
cases are due to het-LOF mutations in PAX6. A proportion of
cases that are clinically indistinguishable from those with non-
sense mutations result from deletions or translocation BPs
located 3′ to the gene (32). A similar phenomenon has also been
observed in holoprosencephaly (MIM 142945), which can be
causedbyhet-LOFmutations inSHHor bydeletions or transloca-
tion BPs in a gene desert 5′ to the gene (33). The mechanism by
which the gene is silenced in these position effects is not yet
clear. The most plausible explanation is that these chromosomal
aberrations disrupt the cis-regulatory landscape of the target
gene via loss of enhancers or insulator elements.
Comparative genomics has provided a powerful tool for iden-
tifying non-coding regions of the genome that are under purify-
ing selectionwithmany of these elements thought to be involved
in cis-regulation of developmental genes (34,35). The identifica-
tionof specific chromatin-associated proteins asmarks of enhan-
cer activity has been another effective approach in the
identification of sequences that are critical for site- and stage-
specific developmental expression of individual genes (36).
Here, both approaches were used in combination with the
human genetic data to identify three CREs that are located
900 kb or more 3′ of SATB2. Like SATB2 itself, these CREs
show remarkable levels of nucleotide identity across evolution.
Each has chromatin marks consistent with enhancer function.
CRE2 andCRE1 indeed show consistent site- and stage-specific
developmental activity in reporter transgenic assays in zebrafish
that at least partly overlaps with the expression pattern of
zfSatb2. However, recent work has shown that not all enhancer
sequences show evolutionary conservation so it is unlikely that
we have identified all significant CREs (37).
While efficient methods now exist to identify DNA regions
with the characteristics of CREs robust methods for identifying
the target of the regulation have yet to be validated. Here, we
have taken the phenotypic similarity of the translocation cases
with the het-LOF mutations as an indication that SATB2 may
be the target ofCRE1–3.Wehave two further pieces of evidence
thatCRE2, at least, is an SATB2 enhancer. The region containing
these distal enhancers shows SATB2 transcription-dependent
chromatin de-condensation, a phenomenon that is common to
many developmentally-regulated loci (7,38). We have also
shown that CRE2 drives expression in multiple independent
stable transgenic lines that drive a subset of the endogenous
zfSatb2 activation domains.
Given the combination of cleft palate and micrognathia in
SATB2 haploinsufficiency cases, there is a clear overlap with
the spectrum of craniofacial malformations seen in genetically
characterized forms of PRS. We have recently shown that a sig-
nificant proportion of isolated autosomal dominant PRS is the
consequence of CRMs affecting the developmental expression
of SOX9 (7,39). Some affected individuals within the SOX9
CRM families had micrognathia as their sole phenotype. We
therefore hypothesized that some or all of the cis-regulation of
SATB2 critical for craniofacial development may be driven by
binding of SOX9. In silico analysis suggested that there were
SOX9-binding sites in each of the elements we had chosen to
study and ChIP-analysis using a SOX9 antibody suggested that
there is binding in cells derived from the mouse embryonic
maxilla and mandible. The fact that disruption of the predicted
SOX9-binding element within CRE2 resulted in a loss of report-
er activity supported our original hypothesis.
The results presented here are consistent with the notion that
the translocation BPs have disrupted the long-range cis-
regulation of SATB2 by SOX9. Identification of small deletions
or point mutations within these elements in cases with PRS
would certainly strengthen the case for a critical role for
CRE2. There are other possible explanations for the association
we have described; the translocations have removed an insulator
region which has resulted in ‘heterochromatinization’ of the
locus. One or more of these elements could function both as an
enhancer and an insulator.
This work has confirmed the existence of a clinically recog-
nizable SATB2-associated syndrome and has provided evidence
that the target region for deleterious mutations affecting this
gene may be much larger than previously thought.
MATERIALS ANDMETHODS
Case ascertainment
Case 1 and Case 2 were ascertained via routine clinical genetics
investigations in a regional genetics service laboratory using
conventional cytogenetic analysis of metaphase chromosomes
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from peripheral blood cells. The FISH mapping experiments
were performed under ethical approval provided by theUKMul-
tiregional Ethics Committee (Reference: 06/MRE00/77) and
imaging and psychometry under ethical approval references
London–Queen Square 01/N078 and 01/N120.
2D metaphase FISH and BP mapping
Metaphase FISH analysis was performed on patient-derived
lymphoblastoid cell line using BAC and P1-derived artificial
chromosome (PAC) clones from theWellcome Trust Sanger In-
stitute (Cambridge, UK) or BACPAC resources (Oakland, CA,
USA) (http://www.chorio.org/bacpac/). Probes labeled with
biotin-16-dUTP or digoxigenin-11-dUTP (Roche, Indianapolis,
IN, USA) were prepared, hybridized and detected as described
previously (40). For each hybridization, five metaphases or
more were analyzed using a Zeiss Axioplan 2 fluorescence
microscope equipped with a triple band-pass filter (#83000 for
DAPI, FITC and Texas Red; Chroma Technology, Brattleboro,
VT, USA). Images were collected using a cooled CCD camera
(Photometrics, CoolSNAP HQ) and analyzed using SmartCap-
ture software (Digital Scientific). Long-range PCR was used to
generate probes for fine BP mapping. Primers were designed
using Primer 3 (http://frodo.wi.mit.edu/cgi-bin/primer3/prim
er3_www.cgi).
3D interphase RNA and DNA FISH on embryonic tissue
sections
Wild-type mouse embryos at 13.5 dpc were fixed, paraffin-
embedded and sectioned at 4 mm. Adjacent slides were used
for RNA FISH, DNA FISH and immunohistochemistry. DNA
FISH was performed as described (41). Mouse BAC probes
were obtained from BACPAC resources Children’s Hospital
Oakland Research Institute. BAC clones were labeled with
digoxigenin-11-dUTP (dig) or the direct fluorescent label
Orange-dUTP (Enzo Life Sciences). Anti-dig antibody conju-
gated to fluorescein (Roche) was used to visualize the
dig-labeled probes. RNA FISH was performed as reported (42)
using a pool of six different 2.5 kb intronic regions ofSatb2 amp-
lified from BAC RP24-241H21 labeled with Orange-dUTP
(Enzo Life Sciences). Two hundred and fifty nanograms of
labeled probe were added to the tissue sections in a final
volume of 10 ml hybridization buffer. After overnight incuba-
tion at 378C, slides were washed; 3 min in 2× SSC/50% forma-
mide at RT, 3 min in 2× SSC/50% formamide at 378C, 3 min in
2× SSC at RT and 3 min in 4× SSC/0 1% Tween. Slides were
mounted in DAPI/Vectashield (Vector Laboratories, Burlin-
game, CA, USA). The imaging system comprises a Hamamatsu
Orca AG CCD camera (Hamamatsu Photonics (UK) Ltd,
WelwynGardenCity, UK), Zeiss Axioskop fluorescencemicro-
scope with plan-neofluar or plan apochromat objectives, a
Lumen 200W metal halide light source (Prior Scientific Instru-
ments, Cambridge, UK) and Chroma #83000 triple band-pass
filter set (Chroma Technology Corp., Rockingham, VT, USA)
with the excitation filters installed in a prior motorized filter
wheel. A piezoelectrically driven objective mount (PIFOC
model P-721, Physik Instrumente GmbH & Co, Karlsruhe,
Germany) was used to control movement in the z-dimension.
Images were deconvolved using the constrained iterative
algorithm of Volocity 6 (Perkinelmer Inc, Waltham, MA,
USA) and inter-spot distances were calculated using the Vel-
ocity 6 quantitation module.
SATB2 antibody production and validation
To express the C-terminal portion of the human SATB2, we
amplified the corresponding fragment from a full-length
SATB2 cDNA clone. An N-terminal HIS-tag was added using
Gateway Technology and the fusion protein expressed from
BL21 (DE3)PLysS competent cells. The protein was purified
using Ni-NTA purification system (Invitrogen) and used for
polyclonal antibody production (CovalAb UK). The resulting
rabbit serum was affinity purified using standard methods. The
antibody was tested by western blot on MEPA cells transfected
with full-length human SATB2 cDNA with an N-terminal GFP
tag in vector pcDNA-DEST 53 (Invitrogen) using the MP-100
Microporator (Digital Bio). Successful transfection of SATB2-
GFPwas confirmed bywestern blot using a 1:2000dilution of af-
finity purifiedSatb2 polyclonal antibody and a1:1000dilution of
monoclonal anti-GFP antibody. Immunohistochemistry was
also performed on 13.5 dpc wild-type and Satb2-null mouse
embryo sections (19).
Immunohistochemistry
Immunohistochemistry was performed on 4 mm paraffin sec-
tions using the VECTASTAIN Elite ABC Kit (Rabbit IgG)
protocol (Vector Laboratories) with some adaptation. For
antigen unmasking, slides were boiled in 10 mM tri-sodium
citrate (pH 6) and subsequently blocked in 1% horse serum/1%
goat serum (PBSTween). Sections were incubated in a 1:100 di-
lution of polyclonal antibody against Satb2 for 30 min. Second-
ary antibody incubation and further steps were carried out
according to protocol. Sections were detected using
ImmPACT DAB (Vector Laboratories).
Identification of CREs and ChIP
Conserved non-coding elements in the PLCL1-SATB2 gene
desert and the orthologous region in the mouse genome were
identified on the basis of conservation in the chick genome of
.80% .150 bp using the ECR browser (http://ecrbrowser.
dcode.org). ChIP was performed as described (43), with
several modifications (details available on request). Chromatin
samples from MEPA cells were immunoprecipitated with 5 mg
of H3K4me1 (ab8895, Abcam), 10 mg of p300(C-20:sc585,
Santacruz), 10 mg of SOX9 (AB5809, Milipore) or 10 mg of
IgG (ab46540, Abcam) antibodies, and the immune complexes
were collected by incubating with protein-A-Dynabeads. The
beads were washed and the immune complexes were eluted
with 50 mM Tris, pH 8.0, 1 mM EDTA and 1% SDS at 658C for
10 min, adjusted to 200 mM NaCl and incubated at 658C over-
night to reverse the cross links. After successive treatments
with 10 mg/ml RNase A and 20 mg/ml proteinase-K, the
samples were eluted into 50 ml H2O using the QIAquick Spin
Gel Purification Kit (Qiagen). The ChIP–qPCR experiments
were carried out using SYBRGreen PCRMasterMix and Light-
Cycler 480 (Roche) platform according to manufacturer’s
instructions using input and ChIP DNA as a template. The
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primers used for the qPCR are shown in Supplementary
Material, Table S6.
Whole-mount in situ hybridization
The zebrafish zfSatb2 antisense probe was made using T7 poly-
merase in vitro transcription as previously described (44).
mCherry and eGFP probes were made with T7 using a template
thatwasPCR-amplifiedusing theprimers listed inSupplementary
Material, Table S7 from the reporter transgenic constructs (see
below).mRNA in situ hybridizationwas performed as previously
described (45). Embryos selected for imaging were mounted in
1% low-melting agarose. Images were taken on Nikon macro-
scope AZ100 and processed using iVision software.
Generation of zebrafish transgenic lines
The cloning of the CRE1–3 and the generation of the zebrafish
transgenic lines bearing the enhancer-reporter constructs was
carried out as described (46). Embryos (F1) from the founders
showing the best representative expression pattern for each con-
struct were selected and processed for WISH, as described
above. At least four-independent transgenic lines were analyzed
for each element, and the images shown are representative of ex-
pression patterns observed for at least 10 embryos from each in-
dependent transgenic line. The details of the primers used for
amplification of the CREs are listed in Supplementary Material,
Table S7.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
ACKNOWLEDGEMENTS
We are grateful to the affected individuals and their families and
carers who made this study possible.
Conflict of Interest statement. None declared.
FUNDING
This work was supported through the UK Medical Research
Council (MRC) core program funding within the MRC Human
Genetic Unit. We are grateful to the Wolfson Trust and the Epi-
lepsy Society for supporting the Epilepsy Society MRI scanner.
This work was, in part, undertaken at UCLH/UCLwho received
a proportion of funding from the Department of Health’s NIHR
UCLH Biomedical Research Centre funding scheme. This
research was also supported by a joint grant from the NIHRBio-
medical Research Centres at UCLH/UCL, Great Ormond Street
Hospital for Children/UCL Institute of Child Health and Moor-
fields Eye Hospital/UCL Institute of Ophthamology (Grant
No.147) and theMRC. Funding to pay theOpenAccess publica-
tion charges for this articlewas provided by theUniversity ofEd-
inburgh Institutional Publication Fund (IPF).
REFERENCES
1. Robin, P. (1923) La chute de la base de la langue consideree comme une
nouvelle cause de gene dans la respiration naso-pharyngienne. Bull. Acad.
Med. Paris, 89, 37–41.
2. Robin, P. (1934)Glossoptosis due to atresia andhypotrophyof themandible.
Arch. Pediatr. Adolesc. Med., 48, 541.
3. Warkany, J. (1971) Congenital malformations. 655, Year Book Medical
Publishers, Chicago, IL.
4. Lee, K.H. and Hayward, P. (2008) Retrospective review of Stickler
syndrome patients with cleft palate 1997–2004.ANZ J. Surg., 78, 764–766.
5. Marques, I.L., Barbieri, M.A. and Bettiol, H. (1998) Etiopathogenesis of
isolated Robin sequence. Cleft Palate Craniofac. J., 35, 517–525.
6. Sheffield, L.J., Reiss, J.A., Strohm, K. and Gilding, M. (1987) A genetic
follow-up study of 64 patients with the Pierre Robin complex. Am. J. Med.
Genet., 28, 25–36.
7. Benko, S., Fantes, J.A., Amiel, J., Kleinjan, D.J., Thomas, S., Ramsay, J.,
Jamshidi, N., Essafi, A., Heaney, S., Gordon, C.T. et al. (2009) Highly
conserved non-coding elements on either side of SOX9 associated with
Pierre Robin sequence. Nat. Genet., 41, 359–364.
8. Bridgewater, L.C., Lefebvre, V. and de Crombrugghe, B. (1998)
Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the
Col2a1 tissue-specific enhancer. J. Biol. Chem., 273, 14998–15006.
9. Brewer, C.M., Leek, J.P., Green, A.J., Holloway, S., Bonthron, D.T.,
Markham,A.F. andFitzPatrick,D.R. (1999)A locus for isolated cleft palate,
located on human chromosome 2q32. Am. J. Hum. Genet., 65, 387–396.
10. FitzPatrick, D.R., Carr, I.M., McLaren, L., Leek, J.P., Wightman, P.,
Williamson, K., Gautier, P., McGill, N., Hayward, C., Firth, H. et al. (2003)
Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum. Mol.
Genet., 12, 2491–2501.
11. Tegay, D.H., Chan, K.K., Leung, L., Wang, C., Burkett, S., Stone, G.,
Stanyon, R., Toriello, H.V. and Hatchwell, E. (2009) Toriello-Carey
syndrome in a patient with a de novo balanced translocation
[46,XY,t(2;14)(q33;q22)] interrupting SATB2. Clin. Genet., 75, 259–264.
12. Baptista, J., Mercer, C., Prigmore, E., Gribble, S.M., Carter, N.P., Maloney,
V., Thomas, N.S., Jacobs, P.A. and Crolla, J.A. (2008) Breakpoint mapping
andarrayCGHin translocations: comparisonof aphenotypicallynormal and
an abnormal cohort. Am. J. Hum. Genet., 82, 927–936.
13. Balasubramanian, M., Smith, K., Basel-Vanagaite, L., Feingold, M.F.,
Brock, P., Gowans, G.C., Vasudevan, P.C., Cresswell, L., Taylor, E.J.,
Harris, C.J. et al. (2011) Case series: 2q33.1 microdeletion syndrome –
further delineation of the phenotype. J. Med. Genet., 48, 290–298.
14. Urquhart, J., Black,G.C. andClayton-Smith, J. (2009) 4.5Mbmicrodeletion
in chromosome band 2q33.1 associated with learning disability and cleft
palate. Eur. J. Med. Genet., 52, 454–457.
15. Van Buggenhout, G., Van Ravenswaaij-Arts, C., McMaas, N., Thoelen, R.,
Vogels, A., Smeets, D., Salden, I., Matthijs, G., Fryns, J.P. and Vermeesch,
J.R. (2005) The del(2)(q32.2q33) deletion syndrome defined by clinical
and molecular characterization of four patients. Eur. J. Med. Genet., 48,
276–289.
16. Rosenfeld, J.A., Ballif, B.C., Lucas, A., Spence, E.J., Powell, C., Aylsworth,
A.S., Torchia, B.A. and Shaffer, L.G. (2009) Small deletions of SATB2
cause some of the clinical features of the 2q33.1 microdeletion syndrome.
PLoS ONE, 4, e6568.
17. Leoyklang, P., Suphapeetiporn, K., Siriwan, P., Desudchit, T.,
Chaowanapanja, P., Gahl, W.A. and Shotelersuk, V. (2007) Heterozygous
nonsense mutation SATB2 associated with cleft palate, osteoporosis, and
cognitive defects. Hum. Mutat., 28, 732–738.
18. Dobreva, G., Dambacher, J. and Grosschedl, R. (2003) SUMOmodification
of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu
gene expression. Genes Dev., 17, 3048–3061.
19. Dobreva, G., Chahrour, M., Dautzenberg, M., Chirivella, L., Kanzler, B.,
Farinas, I., Karsenty, G. and Grosschedl, R. (2006) SATB2 is a
multifunctional determinant of craniofacial patterning and osteoblast
differentiation. Cell, 125, 971–986.
20. Alcamo, E.A., Chirivella, L., Dautzenberg, M., Dobreva, G., Farinas, I.,
Grosschedl, R. and McConnell, S.K. (2008) Satb2 regulates callosal
projection neuron identity in the developing cerebral cortex. Neuron, 57,
364–377.
21. Fishell,G. andHanashima,C. (2008)Pyramidal neuronsgrowupandchange
their mind. Neuron, 57, 333–338.
22. Kolzer, S., Fuss, B., Hoch,M. andKlein, T. (2003)Defective proventriculus
is required for pattern formation along the proximodistal axis, cell
10 Human Molecular Genetics, 2013
 at Edinburgh U
niversity on February 17, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
proliferation and formation of veins in the Drosophila wing. Development,
130, 4135–4147.
23. Shirai, T., Yorimitsu, T., Kiritooshi, N., Matsuzaki, F. and Nakagoshi, H.
(2007) Notch signaling relieves the joint-suppressive activity of defective
proventriculus in the Drosophila leg. Dev. Biol., 312, 147–156.
24. Yorimitsu, T., Kiritooshi, N. and Nakagoshi, H. (2011) Defective
proventriculus specifies theocellar region in theDrosophilahead.Dev.Biol.,
356, 598–607.
25. Fantes, J.A., Boland, E., Ramsay, J., Donnai, D., Splitt, M., Goodship, J.A.,
Stewart, H., Whiteford, M., Gautier, P., Harewood, L. et al. (2008) FISH
mapping of de novo apparently balanced chromosome rearrangements
identifies characteristics associated with phenotypic abnormality.
Am. J. Hum. Genet., 82, 916–926.
26. Ragge, N.K., Lorenz, B., Schneider, A., Bushby, K., de Sanctis, L., de
Sanctis, U., Salt, A., Collin, J.R., Vivian, A.J., Free, S.L. et al. (2005) SOX2
anophthalmia syndrome. Am. J. Med. Genet. A, 135, 1–7. discussion 8.
27. Ghassibe-Sabbagh, M., Desmyter, L., Langenberg, T., Claes, F., Boute, O.,
Bayet, B., Pellerin, P., Hermans, K., Backx, L., Mansilla, M.A. et al. (2011)
FAF1, a gene that is disrupted in cleft palate and has conserved function in
zebrafish. Am. J. Hum. Genet., 88, 150–161.
28. Ghassibe´,M. (2007)Fas-associated factor-1, a protein involved in apoptosis,
causes cleft lip and palate. PhD Thesis. de Duve Institute.
29. Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr,
T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N. et al. (2012) Range
of genetic mutations associated with severe non-syndromic sporadic
intellectual disability: an exomesequencingstudy.Lancet,380, 1674–1682.
30. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A. and
Wysocka, J. (2011) A unique chromatin signature uncovers early
developmental enhancers in humans. Nature, 470, 279–283.
31. Oh, C.D., Maity, S.N., Lu, J.F., Zhang, J., Liang, S., Coustry, F., de
Crombrugghe, B. and Yasuda, H. (2010) Identification of SOX9 interaction
sites in the genome of chondrocytes. PLoS ONE, 5, e10113.
32. Kleinjan, D.J. and van Heyningen, V. (1998) Position effect in human
genetic disease. Hum. Mol. Genet., 7, 1611–1618.
33. Roessler, E., Ward, D.E., Gaudenz, K., Belloni, E., Scherer, S.W., Donnai,
D., Siegel-Bartelt, J., Tsui, L.C. and Muenke, M. (1997) Cytogenetic
rearrangements involving the loss of the SonicHedgehoggene at 7q36 cause
holoprosencephaly. Hum. Genet., 100, 172–181.
34. Clarke, S.L., VanderMeer, J.E.,Wenger, A.M., Schaar, B.T., Ahituv, N. and
Bejerano, G. (2012) Human developmental enhancers conserved between
deuterostomes and protostomes. PLoS Genet., 8, e1002852.
35. Woolfe, A., Goodson, M., Goode, D.K., Snell, P., McEwen, G.K., Vavouri,
T., Smith, S.F., North, P., Callaway, H., Kelly, K. et al. (2005) Highly
conserved non-coding sequences are associated with vertebrate
development. PLoS Biol., 3, e7.
36. Visel, A., Blow, M.J., Li, Z., Zhang, T., Akiyama, J.A., Holt, A.,
Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F. et al. (2009)
ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature,
457, 854–858.
37. Schmidt, D., Wilson, M.D., Ballester, B., Schwalie, P.C., Brown, G.D.,
Marshall, A., Kutter, C.,Watt, S., Martinez-Jimenez, C.P., Mackay, S. et al.
(2010) Five-vertebrate ChIP-seq reveals the evolutionary dynamics of
transcription factor binding. Science, 328, 1036–1040.
38. Chattopadhyay, S., Whitehurst, C.E. and Chen, J. (1998) A nuclear matrix
attachment region upstream of the T cell receptor beta gene enhancer binds
Cux/CDP and SATB1 and modulates enhancer-dependent reporter gene
expression but not endogenous gene expression. J. Biol. Chem., 273,
29838–29846.
39. Gordon, C.T., Tan, T.Y., Benko, S., Fitzpatrick, D., Lyonnet, S. and Farlie,
P.G. (2009) Long-range regulation at the SOX9 locus in development and
disease. J. Med. Genet., 46, 649–656.
40. Chong, S.S., Pack, S.D., Roschke, A.V., Tanigami, A., Carrozzo, R., Smith,
A.C., Dobyns, W.B. and Ledbetter, D.H. (1997) A revision of the
lissencephaly and Miller-Dieker syndrome critical regions in chromosome
17p13.3. Hum. Mol. Genet., 6, 147–155.
41. Chambeyron, S., Da Silva, N.R., Lawson, K.A. and Bickmore,W.A. (2005)
Nuclear re-organisation of the Hoxb complex during mouse embryonic
development. Development, 132, 2215–2223.
42. Finlan,L.E., Sproul,D.,Thomson, I.,Boyle, S.,Kerr,E., Perry, P.,Ylstra,B.,
Chubb, J.R. and Bickmore, W.A. (2008) Recruitment to the nuclear
periphery can alter expression of genes in human cells. PLoS Genet., 4,
e1000039.
43. Soutoglou, E. and Talianidis, I. (2002) Coordination of PIC assembly and
chromatin remodeling during differentiation-induced gene activation.
Science, 295, 1901–1904.
44. Sheehan-Rooney, K., Palinkasova, B., Eberhart, J.K. and Dixon, M.J.
(2010) A cross-species analysis of Satb2 expression suggests
deep conservation across vertebrate lineages. Dev. Dyn., 239,
3481–3491.
45. Thisse, C. and Thisse, B. (2008) High-resolution in situ hybridization to
whole-mount zebrafish embryos. Nat. Protoc., 3, 59–69.
46. Ravi, V., Bhatia, S., Gautier, P., Loosli, F., Tay, B.H., Tay, A.,Murdoch, E.,
Coutinho, P., van Heyningen, V., Brenner, S. et al. (2013) Sequencing of
Pax6 loci fromtheelephant shark reveals a familyofPax6genes invertebrate
genomes, forged by ancient duplications and divergences. PLoS Genet., 9,
e1003177.
Human Molecular Genetics, 201 113
 at Edinburgh U
niversity on February 17, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
